Downregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wu, Qiong ^a   Gou, Yawen ^a,b   Wang, Qiaomin ^b   Jin, Haifeng ^a   Cui, Lina ^a   Zhang, Yongguo ^a   He, Lijie ^a   Wang, Jingbo ^a   Nie, Yongzhan ^a   Shi, Yongquan ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; RIBOSOME PROTEIN; RIBOSOME PROTEIN L6; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; RIBOSOMAL PROTEIN L6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; CELL CYCLE; DOWN REGULATION; DRUG EFFECT; GENETICS; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; RIBOSOMAL PROTEINS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 80054751348     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026401     Document Type: Article

References (32)

1. Lai MD, Xu J, (2007) Ribosomal proteins and colorectal cancer. Curr Genomics 8: 43-49.
2. Ruggero D, Pandolfi PP, (2003) Does the ribosome translate cancer? Nature Reviews Cancer 3: 179-192.
3. Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, et al. (2004) Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2: E139.
4. Kondoh N, Schweinfest CW, Henderson KW, Papas TS, (1992) Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 52: 791-796.
5. Henry JL, Coggin DL, King CR, (1993) High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 53: 1403-1408.
6. Vaarala MH, Porvari KS, Kyllonen AP, Mustonen MV, Lukkarinen O, et al. (1998) Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples. Int J Cancer 78: 27-32.
7. Wang Q, Yang C, Zhou J, Wang X, Wu M, et al. (2001) Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene 263: 205-209.
8. Cheng Q, Lau WM, Chew SH, Ho TH, Tay SK, et al. (2002) Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. Br J Cancer 86: 274-281.
9. Kim J-H, You K-R, Kim IH, Cho B-H, Kim C-Y, et al. (2004) Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology 39: 129-138.
10. Warner JR, McIntosh KB, (2009) How Common Are Extraribosomal Functions of Ribosomal Proteins? Molecular Cell 34: 3-11.
11. Wang X, Lan M, Shi YQ, Lu J, Zhong YX, et al. (2002) Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell. World J Gastroenterol 8: 54-59.
12. Zhao Y, You H, Liu F, An H, Shi Y, et al. (2002) Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 185: 211-218.
13. Du J, Shi Y, Pan Y, Jin X, Liu C, et al. (2005) Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells. Cancer Biol Ther 4: 242-247.
14. Gou Y, Shi Y, Zhang Y, Nie Y, Wang J, et al. (2010) Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells. Biochemical and Biophysical Research Communications 393: 788-793.
15. He S, Zhang D, Cheng F, Gong F, Guo Y, (2009) Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression. Molecular Biology Reports 36: 2153-2163.
16. Hunter AM, LaCasse EC, Korneluk RG, (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568.
17. Danson S, Dean E, Dive C, Ranson M, (2007) IAPs as a target for anticancer therapy. Curr Cancer Drug Targets 7: 785-794.
18. Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, et al. (2003) Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9: 2826-2836.
19. McManus DC, Lefebvre CA, Cherton-Horvat G, St-Jean M, Kandimalla ER, et al. (2004) Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23: 8105-8117.
20. Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, et al. (2007) Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut 56: 782-789.
21. Gong M, Lu Z, Fang G, Bi J, Xue X, (2008) A small interfering RNA targeting osteopontin as gastric cancer therapeutics. Cancer Letters 272: 148-159.
22. Yang XF, Wu CJ, McLaughlin S, Chillemi A, Wang KS, et al. (2001) CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc Natl Acad Sci U S A 98: 7492-7497.
23. Wang Q, Li M, Wang Y, Zhang Y, Jin S, et al. (2008) RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Lett 269: 127-138.
24. Forootan SS, Bao ZZ, Forootan FS, Kamalian L, Zhang Y, et al. (2010) Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts. Int J Oncol 36: 69-76.
25. Guo X, Shi Y, Gou Y, Li J, Han S, et al. (2009) Human ribosomal protein S13 promotes gastric cancer growth through downregulating p27(Kip1). J Cell Mol Med.
26. Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K, et al. (2009) Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int J Cancer 125: 2978-2990.
27. Read RD, Cavenee WK, Furnari FB, Thomas JB, (2009) A drosophila model for EGFR-Ras and PI3K-dependent human glioma. PLoS Genet 5: e1000374.
28. Kim YT, Zhao M, (2005) Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J 46: 597-613.
29. He L, Wang H, Jin H, Guo C, Xie H, et al. (2009) CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 276: 88-94.
30. Zajac-Kaye M, (2001) Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer 34 (Suppl 2): S43-46.
31. Bachmann IM, Ladstein RG, Straume O, Naumov GN, Akslen LA, (2008) Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer 8: 362.
32. Liu N, Bi F, Pan Y, Sun L, Xue Y, et al. (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 10: 6239-6247.